U.S. glaucoma prescription market distribution by product type 2015

Percentage of the glaucoma prescription market in the United States as of 2015, by product type

The data illustrates the percentage of the glaucoma prescription market based on number of prescriptions in the U.S. as of 2015, by product type. As of that year, PGA-product bimatoprost had a market share of 9%.

Bimatoprost 9
Travoprost 8
Latanoprost 35
Beta blocker 13
Fixed combo 15
Alpha agonist 10
Carbonic anhydrase inhibitor 8